Form D · Biotechnology
ProciseDX Inc.
San Diego, CA · CIK 0001819809
Offering snapshot reported Jul 31, 2020 · SEC filing
- Reported sold
- $8.96M Offering amount: $8.96M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 17, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2020 | Initial | $8,957,000 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $507K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-372243
Total amount includes $507,000.00 of warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| CoView Capital, LLC | 35842 |
Source: Form D, filed Jul 31, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Larry Abensur | Director |
| Martin Hendrix | Director |
| Magda Marquet | Director |
| Larry Mimms | Director, Executive |
| Peter Westlake | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9449 Carroll Park Dr
San Diego, CA, 92121
San Diego, CA, 92121